BGIS

BDO exists to solve the complex challenges that businesses face in an increasingly interconnected world. Whether a local enterprise is navigating compliance requirements, a mid-market company is planning expansion, or an organization needs strategic advisory services - BDO provides the expertise and guidance to make confident decisions. Founded in Australia in 1975, BDO has grown to become one of the country's largest associations of independently owned accounting practices, with almost 3,000 people across offices in Adelaide, Brisbane, Cairns, Canberra, Darwin, Gold Coast, Hobart, McLaren Vale, Melbourne, Parramatta, Perth, Sydney, the Sunshine Coast and Townsville. The firm's purpose goes beyond accounting and advisory services - it's about empowering people to realise their possibilities. BDO's values of ONE, BOLD, HUMAN, STRIVE and HEART shape every client interaction and decision. As part of the global BDO network spanning 166 countries, BDO Australia combines local expertise with international reach, helping clients succeed across borders while delivering the personalized attention that defines trusted partnerships. The firm achieved 10% growth year on year, reflecting its commitment to quality-driven service and sustainable client success.

DSM-Firmenich is a global leader in nutrition, health, and beauty, formed from the merger of DSM and Firmenich. The company brings progress to life by combining the essential, the desirable, and the sustainable. With a rich history spanning more than a century, DSM was originally established in 1902 as the Dutch State Mines to mine coal reserves in the southern Netherlands before transforming into a science-based company focused on health, nutrition, and bioscience. Today, DSM-Firmenich operates across multiple business segments including Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care. The company employs approximately 30,000 people across 60+ countries, driven by a purpose to create brighter lives for people today and generations to come. Through scientific innovation and sustainable solutions, the company addresses some of the world's biggest challenges in food systems, climate change, and circular economy.

AbbVie is a global biopharmaceutical company with a mission to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives. When you trust AbbVie with your data, you help advance treatments to some of the world's most difficult health problems, ensuring that patients receive the care they need. The company employs approximately 57,000 people worldwide and operates in 170+ countries, working tirelessly to transform the standard of care across multiple therapeutic areas including immunology, oncology, neuroscience, and more. Founded in 2013 as a separate company from Abbott Laboratories, AbbVie builds on a proud legacy while forging ahead with cutting-edge research and development. The company is committed to being fully transparent and compliant with policies, ensuring fairness and transparency in how personal data is handled. From clinical research to personalized patient support programs, AbbVie puts patients first, developing innovative medicines that have real impact on people's lives around the world.

Genmab is an international biotechnology company that has been transforming cancer treatment for over two decades. Founded in 1999, Genmab has established itself as a leader in antibody therapeutics, with a proven track record of creating breakthrough medicines that improve patients' lives. The company has successfully developed multiple approved antibody therapeutics that are marketed globally, bringing innovative treatments to patients with cancer and other serious diseases. With headquarters in Denmark and offices across the Netherlands, United States, Japan, and the United Kingdom, Genmab operates as a truly global organization. The company's expertise spans the entire antibody development process, from discovery through commercialization, leveraging proprietary technology platforms to create differentiated therapeutics. Genmab's pipeline includes numerous investigational medicines in clinical development, reflecting the company's commitment to pushing the boundaries of antibody science to address unmet medical needs.

BW Energy was founded in 2016 with a bold vision to unlock proven offshore oil and gas reservoirs that others had overlooked. As an independent exploration and production company operating across Gabon, Brazil, and Namibia, BW Energy leverages deep technical expertise and repurposed infrastructure to efficiently extract value from mature fields. The company's infrastructure-led development model minimizes lead times from investment to cash generation while reducing capital exposure - a critical advantage in delivering strong returns at competitive prices. With operated production exceeding 30,000 barrels per day and total resources approaching 600 million barrels, BW Energy has positioned itself for substantial growth through its transformative Maromba development, which aims to triple production to over 90,000 barrels per day by 2028. What truly sets BW Energy apart is its agile, entrepreneurial approach combined with the operational discipline of a proven operator. Rooted in the legacy of BW Group - a global maritime powerhouse with over 80 years of industry leadership - BW Energy inherited deep expertise in offshore infrastructure and a mission to deliver energy responsibly. The company is listed on the Oslo Stock Exchange and continues to execute its strategy of acquiring and developing proven hydrocarbon fields with significant upside potential. By integrating environmental, social, and governance principles into every aspect of operations, BW Energy is not just extracting resources - it's building a sustainable energy future while creating lasting value for stakeholders in the territories where it operates.

Dentsu is an integrated growth and transformation partner to the world's leading organizations. Founded in 1901 in Tokyo, Japan, the company has established itself as a global force in marketing and communications, operating in approximately 120 countries. For over 120 years, innovation has been a core tenet of dentsu's offering - exploring new ways to reach, engage and nurture relationships with audiences. The company combines the talents of its global network of leadership brands to develop impactful and integrated growth solutions for clients, always in pursuit of meaningful outcomes that drive business growth while generating positive effects on industry, society, and the world. Dentsu delivers end-to-end experience transformation by integrating its services across Media, CXM and Creative. The organization was originally established as Japan Advertising Ltd. in 1901 by Hoshiro Mitsunaga, later merging with Telegraphic Service Co. in 1907. In 2013, Dentsu Aegis Network was formed when Dentsu acquired Aegis Group and combined its non-Japanese operations. Since then, the company has rebranded to simply 'dentsu' while maintaining its position as the first global marketing services group built for the digital economy. The network includes global leadership brands such as Dentsu Creative, and operates with a business transformation mindset that pushes boundaries for brands, people and society.